PTPRM and neoplasm: Quantitative RT-PCR analyses of an additional set of 9 trios of non-tumor-adenoma-carcinoma samples also showed decreased expression of PTPRM in 56% (5 of 9) adenoma and 67% (6 of 9) carcinomas (Fig. 3B).